Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Socioeconomic factors associated with chlamydia and gonorrhea positivity in the United States, 2022-2024.

BMC public health·2026
Same author

HIV Preexposure Prophylaxis Prescriptions Among Black and Hispanic or Latino Populations.

JAMA network open·2026
Same author

Genital herpes diagnoses with connecting pharmacological prescriptions among enrollees 18 years and older in a large employer-based healthcare claims data, United States, 2019-2023.

Sexually transmitted diseases·2026
Same author

Trends in HIV Prenatal Testing among Commercially Insured Pregnant Women in the United States, 2011-2022.

Journal of acquired immune deficiency syndromes (1999)·2026
Same author

Quantifying the number of people who would benefit from HIV pre-exposure prophylaxis (PrEP) in the United States: A comparison of behavioral, acquisition-risk based, and economic metrics.

Annals of epidemiology·2026
Same author

Real-World Positive Predictive Value and False Positive Rates of Laboratory-Based HIV Antigen/Antibody Testing by Age and Sex-United States, 2019-2024.

Journal of acquired immune deficiency syndromes (1999)·2025

Related Experiment Video

Updated: May 24, 2026

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections
09:11

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections

Published on: August 11, 2012

Chlamydia testing patterns for commercially insured women, 2008.

Guoyu Tao1, Karen W Hoover, Charlotte K Kent

  • 1Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, Atlanta, Georgia, USA. gat3@cdc.gov

American Journal of Preventive Medicine
|March 20, 2012
PubMed
Summary

Young women are undertested for chlamydia, while older women are overtested, despite recommendations for annual screening. This study examined chlamydia testing patterns in private healthcare settings for women aged 15-44.

More Related Videos

Using Fluorescent Proteins to Visualize and Quantitate Chlamydia Vacuole Growth Dynamics in Living Cells
07:42

Using Fluorescent Proteins to Visualize and Quantitate Chlamydia Vacuole Growth Dynamics in Living Cells

Published on: October 13, 2015

Related Experiment Videos

Last Updated: May 24, 2026

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections
09:11

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections

Published on: August 11, 2012

Using Fluorescent Proteins to Visualize and Quantitate Chlamydia Vacuole Growth Dynamics in Living Cells
07:42

Using Fluorescent Proteins to Visualize and Quantitate Chlamydia Vacuole Growth Dynamics in Living Cells

Published on: October 13, 2015

Area of Science:

  • Reproductive Health
  • Infectious Disease Epidemiology
  • Public Health Policy

Background:

  • Annual chlamydia screening is recommended for sexually active women aged 25 and younger.
  • Chlamydia testing rates have increased, but screening practices vary.
  • Providers often screen all women of reproductive age in public settings.

Purpose of the Study:

  • To analyze chlamydia testing patterns.
  • Focus on private healthcare settings.
  • Examine women aged 15-44 years.

Main Methods:

  • Utilized a large commercial claims database.
  • Estimated chlamydia testing rates for women aged 15-44 in 2008.
  • Identified services and tests using diagnostic and procedural codes.

Main Results:

  • 22.3% of 3.2 million women received chlamydia testing.
  • Testing rates were higher for younger women (34.2% aged 15-25) compared to older women (18.3% aged 26-44).
  • Among tested women, 65% were aged 26-44, with reasons including STD (22.7%) and pregnancy (33.5%).

Conclusions:

  • Younger, insured women are undertested for chlamydia.
  • Older, insured women are overtested for chlamydia.
  • Screening practices require evaluation and improvement.